Pharmaceuticals company Blue Jet Healthcare announced Q3FY25 results Revenue from operations for Q3FY25 stood at Rs 3,184 million which grew 52.9% QoQ compared to Rs 2,083 million in Q2FY25; up 90.9% on YoY basis compared to Rs 1,668 million in Q3FY24. EBITDA for the quarter came at Rs 1,240 million, which was up 78.5% QoQ compared to Rs 695 million in Q2FY25; up 127.2% YoY compared to Rs 546 million in Q3FY24. EBITDA margin for the quarter came at 39.0% as compared to 33.4% in Q2FY25 up 559 bps QoQ; 32.7% in Q3FY24, up 622 bps YoY. Company posted highest ever PAT for the quarter was at Rs 990 million, which grew 69.6% QoQ compared to Rs 583 million; up 208.3% YoY compared to Rs 321 million in Q3FY24. PAT margin for the quarter came at 31.1% as compared to 28.0% in Q2FY25, up 307 bps QoQ; 19.3% in Q3FY24, up 1,183 bps. Result PDF